P&G Hygiene and Healthcare (PGHH) is a 69% subsidiary of the FMCG major - P&G, US. The two-product company is dominating both segments backed by strong brands, namely 'Vicks' in the anti-cold segment and 'Whisper' in feminine care segment (40% market... More
Bajaj Corp. Limited (BCL) is a leading producer of hair oils. It is part of the Shishir Bajaj Group of companies and subsidiary of Bajaj Consumer Care Limited (BCCL). The legacy of BCL began in 1953 when Bajaj Sevashram was established to market and ... More
P&G HYGIENE | BAJAJ CONSUMER CARE | P&G HYGIENE/ BAJAJ CONSUMER CARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 66.2 | 17.1 | 388.1% | View Chart |
P/BV | x | 45.2 | 6.8 | 665.8% | View Chart |
Dividend Yield | % | 0.4 | 6.5 | 5.5% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
P&G HYGIENE Jun-18 |
BAJAJ CONSUMER CARE Mar-19 |
P&G HYGIENE/ BAJAJ CONSUMER CARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 10,360 | 510 | 2,032.2% | |
Low | Rs | 7,891 | 308 | 2,562.0% | |
Sales per share (Unadj.) | Rs | 756.4 | 62.3 | 1,214.7% | |
Earnings per share (Unadj.) | Rs | 115.4 | 15.0 | 768.1% | |
Cash flow per share (Unadj.) | Rs | 131.5 | 15.5 | 848.4% | |
Dividends per share (Unadj.) | Rs | 40.00 | 14.00 | 285.7% | |
Dividend yield (eoy) | % | 0.4 | 3.4 | 12.8% | |
Book value per share (Unadj.) | Rs | 248.2 | 31.7 | 783.2% | |
Shares outstanding (eoy) | m | 32.46 | 147.50 | 22.0% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 12.1 | 6.6 | 183.7% | |
Avg P/E ratio | x | 79.1 | 27.2 | 290.5% | |
P/CF ratio (eoy) | x | 69.4 | 26.4 | 263.1% | |
Price / Book Value ratio | x | 36.8 | 12.9 | 285.0% | |
Dividend payout | % | 34.7 | 93.2 | 37.2% | |
Avg Mkt Cap | Rs m | 296,214 | 60,313 | 491.1% | |
No. of employees | `000 | 0.4 | 1.3 | 28.5% | |
Total wages/salary | Rs m | 1,152 | 972 | 118.6% | |
Avg. sales/employee | Rs Th | 68,392.5 | 7,289.5 | 938.2% | |
Avg. wages/employee | Rs Th | 3,209.7 | 771.2 | 416.2% | |
Avg. net profit/employee | Rs Th | 10,434.3 | 1,758.7 | 593.3% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 24,553 | 9,185 | 267.3% | |
Other income | Rs m | 241 | 170 | 141.5% | |
Total revenues | Rs m | 24,794 | 9,355 | 265.0% | |
Gross profit | Rs m | 6,154 | 2,744 | 224.3% | |
Depreciation | Rs m | 524 | 71 | 738.6% | |
Interest | Rs m | 53 | 12 | 454.7% | |
Profit before tax | Rs m | 5,818 | 2,832 | 205.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2,072 | 616 | 336.6% | |
Profit after tax | Rs m | 3,746 | 2,216 | 169.0% | |
Gross profit margin | % | 25.1 | 29.9 | 83.9% | |
Effective tax rate | % | 35.6 | 21.7 | 163.8% | |
Net profit margin | % | 15.3 | 24.1 | 63.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 8,600 | 4,250 | 202.4% | |
Current liabilities | Rs m | 5,711 | 1,376 | 415.0% | |
Net working cap to sales | % | 11.8 | 31.3 | 37.6% | |
Current ratio | x | 1.5 | 3.1 | 48.8% | |
Inventory Days | Days | 18 | 24 | 75.9% | |
Debtors Days | Days | 22 | 15 | 148.6% | |
Net fixed assets | Rs m | 2,716 | 1,769 | 153.5% | |
Share capital | Rs m | 325 | 148 | 220.1% | |
"Free" reserves | Rs m | 7,730 | 4,526 | 170.8% | |
Net worth | Rs m | 8,055 | 4,674 | 172.4% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 14,254 | 6,052 | 235.5% | |
Interest coverage | x | 110.4 | 243.0 | 45.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.7 | 1.5 | 113.5% | |
Return on assets | % | 26.7 | 36.8 | 72.4% | |
Return on equity | % | 46.5 | 47.4 | 98.1% | |
Return on capital | % | 72.9 | 60.8 | 119.8% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 264 | 123 | 214.2% | |
Fx outflow | Rs m | 5,600 | 26 | 21,713.5% | |
Net fx | Rs m | -5,336 | 97 | -5,487.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 4,155 | 1,764 | 235.6% | |
From Investments | Rs m | -195 | 686 | -28.4% | |
From Financial Activity | Rs m | -1,061 | -2,384 | 44.5% | |
Net Cashflow | Rs m | 2,899 | 62 | 4,683.5% |
Indian Promoters | % | 1.9 | 66.9 | 2.8% | |
Foreign collaborators | % | 68.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 12.3 | 1.6 | 754.6% | |
FIIs | % | 2.4 | 24.5 | 9.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 14.7 | 7.1 | 207.0% | |
Shareholders | 22,617 | 19,219 | 117.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare P&G HYGIENE With: BATA INDIA COLGATE LINC PEN & PLASTICS K.S.OILS JYOTHY LABS
Compare P&G HYGIENE With: P&G (US) UNILEVER PLC. (UK) HYPERMARCAS (Brazil)
Asian share markets are trading on a mixed note today. All eyes are on the US Federal Reserve policy outcome due later today.
For the quarter ended September 2020, P&G HYGIENE has posted a net profit of Rs 3 bn (up 85.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.5% YoY). Read on for a complete analysis of P&G HYGIENE's quarterly results.
For the quarter ended September 2020, BAJAJ CONSUMER CARE has posted a net profit of Rs 573 m (down 0.1% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.
For the quarter ended December 2019, P&G HYGIENE has posted a net profit of Rs 1 bn (up 9.5% YoY). Sales on the other hand came in at Rs 9 bn (up 5.0% YoY). Read on for a complete analysis of P&G HYGIENE's quarterly results.
For the quarter ended December 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 501 m (down 16.7% YoY). Sales on the other hand came in at Rs 2 bn (down 7.9% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.
For the quarter ended September 2019, P&G HYGIENE has posted a net profit of Rs 1 bn (down 5.0% YoY). Sales on the other hand came in at Rs 9 bn (up 7.6% YoY). Read on for a complete analysis of P&G HYGIENE's quarterly results.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More